Myofibre density measurement identifies a critical phase of rapid myofibre loss occurring up to age 6 in early-stage, steroid-naïve Duchenne muscular dystrophy.
Does myofibre density assessment reveal age-related thresholds of myofibre loss in steroid-naïve early-stage DMD?
Myofibre density identifies a critical phase of rapid myofibre loss before age 6 in steroid-naïve DMD patients, highlighting a potential window for early therapeutic intervention.
Absolute Event Rate: 0% vs 0%
MFD, a simple metric, reveals a previously unrecognised phase of rapid myofibre loss lasting up to around age 6 in early-stage DMD.
Yamakado et al. (Wed,) reported a other. Myofibre density measurement identifies a critical phase of rapid myofibre loss occurring up to age 6 in early-stage, steroid-naïve Duchenne muscular dystrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: